InvestorsHub Logo
Followers 1171
Posts 34538
Boards Moderated 0
Alias Born 03/26/2007

Re: omri post# 3689

Wednesday, 07/19/2017 2:27:06 PM

Wednesday, July 19, 2017 2:27:06 PM

Post# of 5873
Look @ the 5 yr Chart...

https://www.google.com/finance?q=imuc&ei=8KJvWcHMJYjijAHB0KToDw

Imagine a Big Pharma will BuyOut this POS!

http://www.prnewswire.com/news-releases/immunocellular-therapeutics-provides-update-on-strategic-review-and-decision-to-suspend-further-patient-randomization-for-ict-107-phase-3-trial-300477190.html

As a result, the Company intends to suspend further patient randomization in the ICT-107 trial while it continues to seek a collaborative arrangement or acquisition of its ICT-107 program. The Company plans to actively work with current collaborators to ensure that patients already randomized and receiving treatment in the phase 3 trial can be appropriately supported and followed
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IMUC News